Organization
ES Therapeutics Australia
2 clinical trials
Clinical trial
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant EpilepsyStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential TremorsStatus: Recruiting, Estimated PCD: 2023-12-31